II Level Master in International Translational Medicine A.Y. 2026/2027
Curriculum
The Master in International Translational Medicine includes lectures and classroom-based teaching, sometimes online, sometimes delivered in person, but always engaging and evidence-based.
The program stands out for its innovative and interdisciplinary educational approach, characterized by a blended, hands-on learning model that combines lectures, intensive modules, practical activities, project work, workshops, and simulations.
The curriculum is stackable and modular, allowing participants to build competencies progressively or focus on specific areas of translational medicine.
Each module carries 9 ECTS and can be taken individually, with a tuition fee of €12,000 per module.
The program is organized into the following thematic modules:
Key Concepts:Translational Medicine, stakeholders, druggability, intellectual property
This module introduces the full translational continuum, starting from unmet medical needs and moving toward effective therapies. Participants explore how scientific discovery, patient needs, regulatory pathways, and intellectual property considerations converge to shape viable translational strategies.
Through real-world examples, the course highlights how decisions on druggability, target selection, and IP protection influence whether promising discoveries can ultimately reach patients.
Key Concepts: Immunology, genetics, epigenetics, bioinformatics, omics-scale data, data science, AI, experimental design
This module focuses on the scientific foundations of target discovery and validation. Participants learn how modern immunology, genetics, epigenetics, and omics technologies are integrated with data science and AI to identify robust and actionable targets.
Emphasis is placed on experimental design, data interpretation, and hypothesis generation, equipping participants to critically evaluate evidence and design translationally relevant research programs.
Key Concepts: Clinical trials, research ethics, scientific writing, post-marketing surveillance
This module covers the clinical phase of translational medicine, from first-in-human studies to post-marketing surveillance. Participants gain insight into clinical trial design, ethical considerations, regulatory requirements, and the generation of high-quality clinical evidence.
The module also strengthens scientific writing skills, enabling participants to communicate results clearly and responsibly to regulators, journals, and the broader scientific and non-scientific community.
Key Concepts: Risk analysis from multiple perspectives, mitigation strategies
Translational Medicine moves discoveries from the lab toward real-world impact: This but the journey is shaped by a diverse set of stakeholders, each with their own priorities, incentives, and risks. This module gives participants a deep, practical understanding of this landscape and equips them with the skills to collaborate, communicate, and make informed decisions across the entire continuum.
Key Concepts: Business models, startups, financing, funding, stakeholder-centric innovation, venture pitching
This module introduces participants to the entrepreneurial dimension of translational medicine. It explores how scientific innovation is transformed into sustainable ventures through appropriate business models, funding strategies, and stakeholder-centric approaches.
Participants learn how to engage investors, industry partners, and other stakeholders, and how to develop and deliver effective venture and industry pitches grounded in translational value and societal impact.
Learning Outcomes
Through interactive sessions, case discussions, and direct engagement with stakeholders, participants learn how scientific, clinical, regulatory, and commercial perspectives intersect. The course also builds advanced communication capabilities, enabling participants to present complex translational pathways through clear data visualizations and compelling narratives tailored to different audiences.
Before each session, participants receive preparatory reading materials that lay the groundwork for meaningful engagement throughout the module.
The teaching activities are complemented by a project work (9 ECTS) and a final examination (6 ECTS) in the form of an individual thesis.
The modular structure enables participants to tailor their learning path to their professional goals while maintaining academic rigor and real-world relevance.
This course helps participants develop the mindset and tools needed to operate effectively in the Translational Medicine ecosystem. You will learn to:
-
Identify and understand the roles, motivations, and risk profiles of key stakeholders;
-
Recognize scientific, operational, regulatory, and commercial risks early and explore strategies to mitigate them;
-
Engage more effectively with clinicians, patients, regulators, payers, and industry partners;
-
Communicate complex scientific and translational concepts using clear, audience-appropriate visualizations;
-
Build persuasive, data-driven narratives that support decision-making and cross-functional collaboration;
-
Contribute more confidently to multidisciplinary teams working on early-stage innovation.
After completing the course, participants will be able to:
-
Anticipate stakeholder concerns and address them proactively;
-
Present research and innovation concepts in ways that resonate with scientific and non-scientific audiences;
-
Navigate cross-functional environments with greater clarity and confidence;
-
Position scientific work within broader clinical, regulatory, and commercial contexts;
-
Reduce uncertainty in early-stage projects through structured analysis and communication.
For leaders and managers in pharma, biotech, government, hospitals and other healthcare organisations, this course delivers clear strategic value. Employees will gain:
-
A deeper understanding of how scientific decisions intersect with regulatory, clinical, and commercial realities;
-
Improved ability to identify and de-risk translational bottlenecks early, saving time and resources;
-
Stronger cross-functional communication skills that support smoother collaboration across RCD, clinical, regulatory, and commercial teams;
-
Enhanced capability to articulate the value, feasibility, and risks of scientific concepts to internal and external stakeholders;
-
A stakeholder-aware mindset that supports strategic decision-making and portfolio progression.
In summary
This course strengthens the analytical, interpersonal, and communicational skills required to navigate the multi-stakeholder environment of Translational Medicine. Participants gain a holistic understanding of the innovation pathway and learn how to translate scientific discoveries into viable development strategies. Organisations benefit from employees who think more strategically, communicate more effectively, and contribute more confidently to the advancement of promising discoveries.